The biotech industry is expected to grow steadily due to drug advancements, chronic disease treatment demand, personalized medicine, gene therapies, an aging population, and rising healthcare expenditures.
Given the industry’s growth prospects, investors could consider buying fundamentally sound biotech stocks Theratechnologies Inc. (THTX), Gilead Sciences, Inc. (GILD), and Exelixis, Inc. (EXEL) for solid returns.
